Metabolism of the Antituberculosis Drug Ethionamide

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|14|1|151-158

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.14, Iss.1, 2013-01, pp. : 151-158

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cutaneous Adverse Drug Reactions Caused by Antituberculosis Drugs

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 4, 2014-08 ,pp. : 241-248

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Biology in Anti-Tuberculosis Drug Discovery

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 3, 2009-06 ,pp. : 319-326

Bentham Science Publishers

Access to resources Recommend Favorite

Lessons from Seven Decades of Antituberculosis Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 10, 2011-05 ,pp. : 1216-1225

Bentham Science Publishers

Access to resources Recommend Favorite

Drug–drug interactions and tolerance in combining antituberculosis and antiretroviral therapy

By Di Perri Giovanni   Aguilar Marucco Diego   Mondo Alessandra   Gonzalez de Requena Daniel   Audagnotto Sabrina   Gobbi Federico   Bonora Stefano  

Expert Opinion on Drug Safety, Vol. 4, Iss. 5, 2005-09 ,pp. : 821-836

Informa Healthcare

Access to resources Recommend Favorite

Anti-Tuberculosis Drug Induced Hepatotoxicity and Genetic Polymorphisms in Drug-metabolizing Genes

By  

Current Pharmacogenomics, Vol. 1, Iss. 2, 2003-01 ,pp. : 101-109

Bentham Science Publishers

Access to resources Recommend Favorite